BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9669168)

  • 1. [The adjuvant and specific activity of transfer factors to Candida albicans antigens].
    Borysov VA; Cheusova ZV; Molozhava OS
    Fiziol Zh (1994); 1998; 44(4):3-9. PubMed ID: 9669168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The isolation of a transfer factor of the delayed-hypersensitivity type to the antigenic substances of Staphylococcus aureus in guinea pigs].
    Holieva OH; Liubchenko TA; Kholodna LS; Vershihora AIu
    Fiziol Zh (1994); 1996; 42(5-6):58-65. PubMed ID: 9044813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human specific transfer factor to Staphylococcus aureus antigens].
    Liubchenko TA; Holeva OH; Kholodna LS; Stepanchuk VA; Vershyhora AIu
    Fiziol Zh (1994); 1997; 43(3-4):25-32. PubMed ID: 9303798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfer of delayed type hypersensitivity in guinea pigs].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nature of the cells regulating the production of a migration inhibition factor in C57BL/6 strain mice with low response to Candida albicans antigen].
    Vorob'ev KV; Koval'chuk LV; Gankovskaia LV
    Biull Eksp Biol Med; 1984 Nov; 98(11):601-2. PubMed ID: 6239664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of human transfer factor on the migration of guinea-pig macrophages: is there an antigen-specific activity?
    Sargent IL; Salaman MR
    Immunology; 1980 Sep; 41(1):227-35. PubMed ID: 6159314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
    Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
    J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract.
    Sen P; Smith JK; Buse M; Hsieh HC; Lavenhar MA; Lintz D; Louria DB
    Sabouraudia; 1982 Jun; 20(2):85-93. PubMed ID: 7051369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine transfer factor. I. Description of the model and evidence for specificity.
    Petersen EA; Greenberg LE; Manzara T; Kirkpatrick CH
    J Immunol; 1981 Jun; 126(6):2480-4. PubMed ID: 6164731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
    Wilson GB; Fudenberg HH; Keller RH
    J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of delayed-type hypersensitivity and interferon-gamma to Candida albicans and anti-hen-egg white lysozyme antibody as phenotypic markers of enhanced bovine immune response.
    Heriazon A; Yager JA; Sears W; Mallard BA
    Vet Immunol Immunopathol; 2009 May; 129(1-2):93-100. PubMed ID: 19155071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfer factor (TF) - a modulator of immunological activity].
    Grubek-Jaworska H; Komorowska-Rycerz A
    Postepy Hig Med Dosw; 1981; 35(6):549-74. PubMed ID: 6752921
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
    Rocklin RE
    Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of influenza in mice by transfer factor therapy.
    Olson GB; Drube CG
    J Reticuloendothel Soc; 1978 Nov; 24(5):589-99. PubMed ID: 366134
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfer factor in chronic mucocutaneous candidiasis.
    Masi M; De Vinci C; Baricordi OR
    Biotherapy; 1996; 9(1-3):97-103. PubMed ID: 8993766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes.
    Górski A; Madalinska M; Droszcz W
    Biomedicine; 1973 Jan; 19(1):19-21. PubMed ID: 4593322
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes.
    Górski A; Madalińska M; Droszcz W
    Biomedicine; 1973 Jan; 19(1):19-21. PubMed ID: 4575691
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evans blue as an adjuvant for enhancing delayed hypersensitivity in an experiment].
    Podoplelov II; Krylov OR; Medunitsyn NV
    Biull Eksp Biol Med; 1985 Jun; 99(6):729-31. PubMed ID: 4016266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interstrain differences in mice in developing migration inhibition factors to Candida albicans antigens].
    Vorob'ev KV; Gankovskaia LV; Koval'chuk LV; Shabanova LF
    Biull Eksp Biol Med; 1983 Oct; 96(10):80-2. PubMed ID: 6354302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.
    Thomson AW; Moon DK; Inoue Y; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):301-8. PubMed ID: 6822404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.